197 related articles for article (PubMed ID: 1639466)
1. Adverse effect of the calcium channel blocker nitrendipine on nephrosclerosis in rats with renovascular hypertension.
Wenzel UO; Troschau G; Schoeppe W; Helmchen U; Schwietzer G
Hypertension; 1992 Aug; 20(2):233-41. PubMed ID: 1639466
[TBL] [Abstract][Full Text] [Related]
2. Combination treatment of enalapril with nitrendipine in rats with renovascular hypertension.
Wenzel UO; Helmchen U; Schoeppe W; Schwietzer G
Hypertension; 1994 Jan; 23(1):114-22. PubMed ID: 8282322
[TBL] [Abstract][Full Text] [Related]
3. Systemic and renal effect of chronic omapatrilat in sodium-restricted, one-kidney, one-clip hypertensive rats.
Jover B; Stuit L; Mimran A
J Hypertens; 2004 Feb; 22(2):383-8. PubMed ID: 15076198
[TBL] [Abstract][Full Text] [Related]
4. Effects of chronic treatment with angiotensin converting enzyme inhibitor or an angiotensin receptor antagonist in two-kidney, one-clip hypertensive rats.
Imamura A; Mackenzie HS; Lacy ER; Hutchison FN; Fitzgibbon WR; Ploth DW
Kidney Int; 1995 May; 47(5):1394-402. PubMed ID: 7637269
[TBL] [Abstract][Full Text] [Related]
5. Nitrendipine and enalapril improve albuminuria and glomerular filtration rate in non-insulin dependent diabetes.
Mosconi L; Ruggenenti P; Perna A; Mecca G; Remuzzi G
Kidney Int Suppl; 1996 Jun; 55():S91-3. PubMed ID: 8743521
[TBL] [Abstract][Full Text] [Related]
6. Effects of enalapril and nitrendipine on the excretion of epidermal growth factor and albumin in hypertensive NIDDM patients.
Josefsberg Z; Ross SA; Lev-Ran A; Hwang DL
Diabetes Care; 1995 May; 18(5):690-3. PubMed ID: 8586009
[TBL] [Abstract][Full Text] [Related]
7. Effects of nitrendipine and cilazapril on renal hemodynamics and albuminuria in hypertensive patients with chronic renal failure.
Kloke HJ; Wetzels JF; van Hamersvelt HW; Koene RA; Kleinbloesem CH; Huysmans FT
J Cardiovasc Pharmacol; 1990 Dec; 16(6):924-30. PubMed ID: 1704985
[TBL] [Abstract][Full Text] [Related]
8. Contrasting renal effects of chronic administrations of enalapril and losartan on one-kidney, one clip hypertensive rats.
Demeilliers B; Jover B; Mimran A
J Hypertens; 1998 Jul; 16(7):1023-9. PubMed ID: 9794744
[TBL] [Abstract][Full Text] [Related]
9. Acute effects of angiotensin II receptor antagonist on autoregulation of zonal glomerular filtration rate in renovascular hypertensive rats.
Wang X; Aukland K; Iversen BM
Kidney Blood Press Res; 1997; 20(4):225-32. PubMed ID: 9398027
[TBL] [Abstract][Full Text] [Related]
10. ACE inhibition prevents and reverses L-NAME-exacerbated nephrosclerosis in spontaneously hypertensive rats.
Ono H; Ono Y; Frohlich ED
Hypertension; 1996 Feb; 27(2):176-83. PubMed ID: 8567038
[TBL] [Abstract][Full Text] [Related]
11. Comparison of systemic and regional hemodynamic effects of a diuretic, an angiotensin II receptor antagonist, and an angiotensin-converting enzyme inhibitor in conscious renovascular hypertensive rats.
Wang YX; Gavras I; Wierzba T; Gavras H
J Lab Clin Med; 1992 Mar; 119(3):267-72. PubMed ID: 1541876
[TBL] [Abstract][Full Text] [Related]
12. Long-term treatment with either enalapril or nitrendipine stabilizes albuminuria and increases glomerular filtration rate in non-insulin-dependent diabetic patients.
Ruggenenti P; Mosconi L; Bianchi L; Cortesi L; Campana M; Pagani G; Mecca G; Remuzzi G
Am J Kidney Dis; 1994 Nov; 24(5):753-61. PubMed ID: 7977316
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin converting enzyme inhibition ameliorates glomerular filtration of macromolecules and water and lessens glomerular injury in the rat.
Remuzzi A; Puntorieri S; Battaglia C; Bertani T; Remuzzi G
J Clin Invest; 1990 Feb; 85(2):541-9. PubMed ID: 1688888
[TBL] [Abstract][Full Text] [Related]
14. Cardiorenal protective effects of year-long antihypertensive therapy with an angiotensin-converting enzyme inhibitor or a calcium channel blocker in spontaneously hypertensive rats.
Ishimitsu T; Honda T; Ohta S; Akashiba A; Takahashi T; Kameda T; Yoshii M; Minami J; Takahashi M; Ono H; Matsuoka H
Am J Hypertens; 2006 Dec; 19(12):1233-40. PubMed ID: 17161768
[TBL] [Abstract][Full Text] [Related]
15. N- and L-type calcium channel antagonist improves glomerular dynamics, reverses severe nephrosclerosis, and inhibits apoptosis and proliferation in an l-NAME/SHR model.
Zhou X; Ono H; Ono Y; Frohlich ED
J Hypertens; 2002 May; 20(5):993-1000. PubMed ID: 12011661
[TBL] [Abstract][Full Text] [Related]
16. Hyperfiltration and conservation of renal function in hypertensive nephrosclerosis patients.
Lee HC; Mitchell HC; Van Dreal P; Pettinger WA
Am J Kidney Dis; 1993 Apr; 21(4 Suppl 1):68-74. PubMed ID: 8465839
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of enalapril and nitrendipine on the fibrinolytic system in essential hypertension.
Sakata K; Shirotani M; Yoshida H; Urano T; Takada Y; Takada A
Am Heart J; 1999 Jun; 137(6):1094-9. PubMed ID: 10347337
[TBL] [Abstract][Full Text] [Related]
18. Impairment and recovery of the clipped kidney in two kidney, one clip hypertensive rats during and after antihypertensive therapy.
Gröne HJ; Helmchen U
Lab Invest; 1986 Jun; 54(6):645-55. PubMed ID: 3012198
[TBL] [Abstract][Full Text] [Related]
19. Nitrendipine and enalapril in the treatment of diabetic hypertensive patients with microalbuminuria.
Piñol C; Cobos A; Cases A; Esmatges E; Soler J; Closas J; Pascual R; Planas J
Kidney Int Suppl; 1996 Jun; 55():S85-7. PubMed ID: 8743519
[TBL] [Abstract][Full Text] [Related]
20. Pharmacologic nephrectomy with chronic angiotensin converting enzyme inhibitor treatment in renovascular hypertension in the rat.
Jackson B; Franze L; Sumithran E; Johnston CI
J Lab Clin Med; 1990 Jan; 115(1):21-7. PubMed ID: 2299253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
